Drawing for EXPERT OPINION

USPTO serial 79118677

EXPERT OPINION

Reviewed by CopyMark Law Group

Reg. 4499914Status 404
Filing date
Status date
Registration date
Mar 25, 2014
Examiner
KON, ELISSA GARBER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXPERT OPINION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable electronic publications in the nature of journals, articles, magazines, bulletins and newspapers featuring information in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet; computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare recorded on computer media all recorded magnetically, optically or electronicallySECTION 71 - CANCELLED—
016Paper, cardboard and goods made from these materials, not included in other classes, namely, boxes, cartons, storage containers, and packaging containers; printed matter, namely, journals, newsletters, reports, and directories featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; printed matter, namely, reports, journals, articles, magazines, books, newspapers, news bulletins, newsletters and brochures relating to computer software and programmes; book-binding material; photographs; stationery; instructional and teaching materials other than apparatus, namely, journals, articles, newsletters and seminar notes in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcareSECTION 71 - CANCELLED—
041Education services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; providing training in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; entertainment and recreational services, namely, arranging and conducting of sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; the provision of online, nondownloadable publications in the nature of journals, articles, magazines, bulletins and newspapers featuring information in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare disseminated via the Internet; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the InternetSECTION 71 - CANCELLED—
042Industrial analysis and research services, namely, medical research; provision of information, including the online provision of such information, relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; design and development of computer hardware and software; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; technical consultancy and advisory services in the field of computer hardware and software; consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer timesharing; research and development of computer hardware and software; technological services relating to computers; rental and leasing of computers; computer programming; computer rental and updating of computer software; computer software design; hosting of websites; hosting of digital content in the nature of online journals and blogs; technical consultancy and advisory services in the field of computer networks; technical support services, namely, troubleshooting of computer software problems via computer help-lines; technical support services, namely, troubleshooting relating to computer hardware, computer software, computer networks and the Internet; hosting on-line web facilities for the search, retrieval, indexing and organization of data on electronic communication networks and for enhancing the performance and function of such networks; database design and development; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the InternetSECTION 71 - CANCELLED—
044Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; medical consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; pharmaceutical advisory services; the provision of information relating to pharmaceuticals; dispensing of pharmaceuticals; veterinary services; preparation of medical reports; issuing of medical reports; advisory services and the provision of information relating to surgery, including cosmetic surgery; advisory services and the provision of information relating to cosmetic treatment in the nature of cosmetic and plastic surgery, cosmetic skin care services, cosmetic peels; hygienic and beauty care for human beings or animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the InternetSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2022UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Aug 21, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 21, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 12, 2021INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 17, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 17, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Oct 8, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 12, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 26, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 26, 2014FIMPFINAL DISPOSITION PROCESSED—
Jun 25, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 3, 2014OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 19, 2014OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 7, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2014GPNXNOTIFICATION PROCESSED BY IB—
Dec 18, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 18, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 18, 2013NPUBNOTICE OF PUBLICATION—
Dec 5, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 5, 2013ALIEASSIGNED TO LIE—
Nov 12, 2013CNEAEXAMINERS AMENDMENT MAILED—
Nov 12, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Nov 12, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 8, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2013CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 19, 2012RFNTREFUSAL PROCESSED BY IB—
Nov 1, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 1, 2012RFRRREFUSAL PROCESSED BY MPU—
Nov 1, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 31, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 24, 2012DOCKASSIGNED TO EXAMINER—
Oct 24, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance